Dimensional Fund Advisors
ALBO

Dimensional Fund Advisors’s Albireo Pharma Inc ALBO Stock Holding History

Dimensional Fund Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$5.12M Sell
264,536
-124,321
-32% -$2.57M ﹤0.01% 2417
2022
Q2 		$7.72M Buy
388,857
+27,796
+8% +$733K ﹤0.01% 2308
2022
Q1 		$10.8M Buy
361,061
+34,486
+11% +$1.01M ﹤0.01% 2264
2021
Q4 		$7.61M Buy
326,575
+13,107
+4% +$348K ﹤0.01% 2414
2021
Q3 		$9.78M Sell
313,468
-71,626
-19% -$2.22M ﹤0.01% 2339
2021
Q2 		$13.5M Buy
385,094
+32,051
+9% +$1.04M ﹤0.01% 2224
2021
Q1 		$12.4M Buy
353,043
+64,607
+22% +$2.39M ﹤0.01% 2240
2020
Q4 		$10.8M Buy
288,436
+40,716
+16% +$1.48M ﹤0.01% 2250
2020
Q3 		$8.27M Buy
247,720
+3,632
+1% +$106K ﹤0.01% 2279
2020
Q2 		$6.47M Buy
244,088
+9,096
+4% +$215K ﹤0.01% 2379
2020
Q1 		$3.85M Buy
234,992
+16,324
+7% +$359K ﹤0.01% 2508
2019
Q4 		$5.56M Buy
218,668
+2,726
+1% +$54.5K ﹤0.01% 2577
2019
Q3 		$4.32M Buy
215,942
+7,542
+4% +$195K ﹤0.01% 2644
2019
Q2 		$6.72M Buy
208,400
+48,710
+31% +$1.63M ﹤0.01% 2557
2019
Q1 		$5.14M Buy
159,690
+43,467
+37% +$1.17M ﹤0.01% 2641
2018
Q4 		$2.85M Buy
116,223
+33,390
+40% +$883K ﹤0.01% 2759
2018
Q3 		$2.73M Buy
82,833
+69,431
+518% +$2.27M ﹤0.01% 2850
2018
Q2 		$476K Buy
+13,402
New +$434K ﹤0.01% 3133
2015
Q3 		– Sell
-1,846
Closed -$57K – 3377
2015
Q2 		$57K Sell
1,846
-3
-0.2% -$101 ﹤0.01% 3333
2015
Q1 		$66K Hold
1,849
– – ﹤0.01% 3295
2014
Q4 		$74K Hold
1,849
– – ﹤0.01% 3342
2014
Q3 		$93K Sell
1,849
-13
-0.7% -$747 ﹤0.01% 3344
2014
Q2 		$121K Hold
1,862
– – ﹤0.01% 3356
2014
Q1 		$152K Hold
1,862
– – ﹤0.01% 3339
2013
Q4 		$128K Hold
1,862
– – ﹤0.01% 3332
2013
Q3 		$176K Sell
1,862
-39
-2% -$5.08K ﹤0.01% 3329
2013
Q2 		$238K Buy
+1,901
New +$198K ﹤0.01% 3289

Other funds holding ALBO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Dimensional Fund Advisors's ALBO Position: Q3 2022 in Review

Dimensional Fund Advisors reduced its Albireo Pharma Inc (ALBO) stake by 32% in Q3 2022, selling an estimated $2.57M and leaving 264,536 shares worth $5.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2417.

Dimensional Fund Advisors first reported a position in ALBO in Q2 2013 and has held it in 27 quarters since. The position peaked at $13.5M in Q2 2021. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • Dimensional Fund Advisors held 264,536 shares of Albireo Pharma Inc worth $5.12M as of Q3 2022.
  • Dimensional Fund Advisors sold 124,321 Albireo Pharma Inc shares in Q3 2022, an estimated $2.57M.
  • Albireo Pharma Inc made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #2417 holding.
  • Dimensional Fund Advisors first reported a position in Albireo Pharma Inc in Q2 2013 and has held it in 27 quarters since.
  • Dimensional Fund Advisors's Albireo Pharma Inc position peaked at $13.5M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.